Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06466603 · ClinicalTrials.gov registry record
Probiotics for Anxiety Study
A clinical trial of Anxiety, sponsored by Verb Biotics.
- Active
- Registry status
- 122
- Enrollment target
- 1
- Study location
NCT06466603 is a study of Anxiety that is active but no longer recruiting, run by Verb Biotics. The registered enrollment target is 122 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06466603, a study of Anxiety, is active but no longer recruiting, sponsored by Verb Biotics.
- ACTIVE NOT RECRUITING
- Registry status
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe the effect of a consumer-grade probiotic capsule called GABA (gamma-aminobutyric acid ) Probiotic ("Study Product"), a probiotic capsule containing Lactiplantibacillus plantarum 815, on anxiety. The purpose of this study is to evaluate the effects of 2 different doses of this probiotic study product on anxiety in comparison to placebo. Additionally, the study aims to observe the effects of the probiotic study product on mood, cognitive function, quality of life and sleep. After the 6-week study product use period, all participants will be given the option to continue using GABA Probiotic for an additional 4 weeks. Participants in this study will complete surveys and questionnaires about their experience before, during and after taking the study product. Additionally, this study will incorporate the use of a wrist-worn electronic device to measure sleep.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo Group
- DIETARY_SUPPLEMENT GABA Probiotic Dose 1
- DIETARY_SUPPLEMENT GABA Probiotic Dose 2
Study Locations (1)
California
- People Science, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2025-02-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06466603
The ClinicalTrials.gov registry entry for NCT06466603 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (72% lower). The listed sponsor is Verb Biotics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Placebo Group is the first listed.
NCT06466603 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06466603 about?
NCT06466603 is a clinical study titled "Probiotics for Anxiety Study". The purpose of this study is to observe the effect of a consumer-grade probiotic capsule called GABA (gamma-aminobutyric acid ) Probiotic ("Study Product"), a probiotic capsule containing Lactiplantibacillus plantarum 815, on anxiety. The purpose of this study is to evaluate the effects of 2 differe...
What is the current status of trial NCT06466603?
This trial is currently active not recruiting. The enrollment target is 122 participants. The study started on 2024-03-04. Estimated completion is 2025-02-11.
What conditions does trial NCT06466603 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT06466603?
The interventions under investigation include: Placebo Group (DIETARY_SUPPLEMENT), GABA Probiotic Dose 1 (DIETARY_SUPPLEMENT), GABA Probiotic Dose 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06466603?
This trial is sponsored by Verb Biotics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06466603 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.